These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Multimodality therapy concepts in esophageal carcinoma]. Siewert JR; Ott K Kongressbd Dtsch Ges Chir Kongr; 2001; 118():39-43. PubMed ID: 11824282 [TBL] [Abstract][Full Text] [Related]
23. Multidisciplinary approach to esophageal and gastric cancer. Stein HJ; Sendler A; Fink U; Siewert JR Surg Clin North Am; 2000 Apr; 80(2):659-82; discussions 683-6. PubMed ID: 10836011 [TBL] [Abstract][Full Text] [Related]
24. The current optimal multimodality treatments for oesophageal squamous-cell carcinoma: A systematic review and meta-analysis. Li F; Ding N; Zhao Y; Yuan L; Mao Y Int J Surg; 2018 Dec; 60():88-100. PubMed ID: 30389537 [TBL] [Abstract][Full Text] [Related]
25. Curative treatment for esophageal cancer: Vancouver Island Cancer Centre experience from 1993 to 1998. Wilson KS; Wilson AG; Dewar GJ Can J Gastroenterol; 2002 Jun; 16(6):361-8. PubMed ID: 12096299 [TBL] [Abstract][Full Text] [Related]
26. A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction. Ajani JA; Komaki R; Putnam JB; Walsh G; Nesbitt J; Pisters PW; Lynch PM; Vaporciyan A; Smythe R; Lahoti S; Raijman I; Swisher S; Martin FD; Roth JA Cancer; 2001 Jul; 92(2):279-86. PubMed ID: 11466680 [TBL] [Abstract][Full Text] [Related]
27. Diagnosis and therapy in advanced cancer of the esophagus and the gastroesophageal junction. Lerut T; Coosemans W; Decker G; De Leyn P; Moons J; Nafteux P; Van Raemdonck D Curr Opin Gastroenterol; 2006 Jul; 22(4):437-41. PubMed ID: 16760764 [TBL] [Abstract][Full Text] [Related]
28. A single institutional non-randomized retrospective comparison between definitive chemoradiotherapy and radical surgery in 82 Japanese patients with resectable esophageal squamous cell carcinoma. Yamashita H; Nakagawa K; Yamada K; Kaminishi M; Mafune K; Ohtomo K Dis Esophagus; 2008; 21(5):430-6. PubMed ID: 19125797 [TBL] [Abstract][Full Text] [Related]
29. Multidisciplinary Therapy of Esophageal Cancer. Egyud MR; Tseng JF; Suzuki K Surg Clin North Am; 2019 Jun; 99(3):419-437. PubMed ID: 31047033 [TBL] [Abstract][Full Text] [Related]
30. Advanced Age is Not a Contraindication for Treatment With Curative Intent in Esophageal Cancer. Voncken FEM; van der Kaaij RT; Sikorska K; van Werkhoven E; van Dieren JM; Grootscholten C; Snaebjornsson P; van Sandick JW; Aleman BMP Am J Clin Oncol; 2018 Sep; 41(9):919-926. PubMed ID: 28763327 [TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant treatments for locally advanced, resectable esophageal cancer: A network meta-analysis. Chan KKW; Saluja R; Delos Santos K; Lien K; Shah K; Cramarossa G; Zhu X; Wong RKS Int J Cancer; 2018 Jul; 143(2):430-437. PubMed ID: 29441562 [TBL] [Abstract][Full Text] [Related]
33. Combined Modality Therapy for Management of Esophageal Cancer: Current Approach Based on Experiences from East and West. Moaven O; Wang TN Surg Clin North Am; 2019 Jun; 99(3):479-499. PubMed ID: 31047037 [TBL] [Abstract][Full Text] [Related]
34. Comparison of curative surgery and definitive chemoradiotherapy as initial treatment for patients with cervical esophageal cancer. Takebayashi K; Tsubosa Y; Matsuda S; Kawamorita K; Niihara M; Tsushima T; Yokota T; Sato H; Onozawa Y; Ogawa H; Kamijo T; Onitsuka T; Nakagawa M; Yasui H Dis Esophagus; 2017 Feb; 30(2):1-5. PubMed ID: 27859977 [TBL] [Abstract][Full Text] [Related]
35. The role of multimodality therapy for resectable esophageal cancer. Meneu-Diaz JC; Blazquez LA; Vicente E; Nuño J; Quijano Y; Lopez-Hervás P; Devesa M; Fresneda V Am J Surg; 2000 Jun; 179(6):508-13. PubMed ID: 11004342 [TBL] [Abstract][Full Text] [Related]
36. Neoadjuvant chemotherapy for resectable esophageal carcinoma: a meta-analysis of randomized clinical trials. Xu XH; Peng XH; Yu P; Xu XY; Cai EH; Guo P; Li K Asian Pac J Cancer Prev; 2012; 13(1):103-10. PubMed ID: 22502650 [TBL] [Abstract][Full Text] [Related]
37. Defining the optimal treatment of locally advanced esophageal cancer: a systematic review and decision analysis. Graham AJ; Shrive FM; Ghali WA; Manns BJ; Grondin SC; Finley RJ; Clifton J Ann Thorac Surg; 2007 Apr; 83(4):1257-64. PubMed ID: 17383322 [TBL] [Abstract][Full Text] [Related]
38. Complete 5-year follow-up of a prospective phase II trial of preoperative chemoradiotherapy for esophageal cancer. Posner MC; Gooding WE; Lew JI; Rosenstein MM; Lembersky BC Surgery; 2001 Oct; 130(4):620-6; discussion 626-8. PubMed ID: 11602892 [TBL] [Abstract][Full Text] [Related]